Esperion Therapeutics, Inc.·4

May 10, 4:12 PM ET

Koenig Sheldon L. 4

4 · Esperion Therapeutics, Inc. · Filed May 10, 2023

Insider Transaction Report

Form 4
Period: 2023-05-09
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-05-09$1.26/sh+20,000$25,192312,816 total

Documents

1 file
  • 4
    wf-form4_168374953131146.xmlPrimary

    FORM 4